These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10882181)

  • 1. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches.
    Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA
    Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody therapy of acute myelogenous leukemia.
    Jurcic JG
    Cancer Biother Radiopharm; 2000 Aug; 15(4):319-26. PubMed ID: 11041016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative strategies in lymphoma therapy.
    Jäger U
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):462-70. PubMed ID: 13677264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody therapy in acute myeloid leukemia: current status and future directions.
    Burke JM; Jurcic JG
    Clin Lymphoma; 2002 Mar; 2 Suppl 1():S12-8. PubMed ID: 11970765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody therapy in non-Hodgkin's lymphoma: the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab.
    Fietz T; Thiel E
    Recent Results Cancer Res; 2007; 176():153-63. PubMed ID: 17607923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
    Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
    Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
    Mihăilă RG
    Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular Immunotherapy for Hematologic Malignancies: Beyond Bone Marrow Transplantation.
    Cirillo M; Tan P; Sturm M; Cole C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):433-442. PubMed ID: 29102721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
    Maloney DG
    J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.
    Gadri Z; Kukulansky T; Bar-Or E; Haimovich J; Hollander N
    J Immunother; 2009 May; 32(4):333-40. PubMed ID: 19342972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody immunotherapy for leukemia.
    Jurcic JG
    Curr Oncol Rep; 2000 Mar; 2(2):114-22. PubMed ID: 11122832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational development of active immunotherapy for hematologic malignancies.
    Kwak LW
    Semin Oncol; 2003 Jun; 30(3 Suppl 8):17-22. PubMed ID: 12881808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
    Epner EM; Saroya BS; Hasanali ZS; Loughran TP
    Exp Hematol; 2016 Mar; 44(3):157-60. PubMed ID: 26802532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-based treatment of acute myeloid leukaemia.
    Mulford DA; Jurcic JG
    Expert Opin Biol Ther; 2004 Jan; 4(1):95-105. PubMed ID: 14680472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody therapy of lymphoma.
    Illidge TM; Bayne MC
    Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for immunotherapy of cancer.
    Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R
    Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.